Please create an account to participate in the Slashdot moderation system

 



Forgot your password?
typodupeerror
×
Biotech Medicine Science

FDA OKs First Human Trial of Neural Stem Cell Therapy 149

An anonymous reader sends word that the FDA has approved a phase 1 trial for Neuralstem, a company with a patented stem cell procedure targeting ALS (Lou Gehrig's disease) and other spinal conditions. The company's CEO said in a press release, "While this trial aims to primarily establish safety and feasibility data in treating ALS patients, we also hope to be able to measure a slowing down of the ALS degenerative process." Results are expected in 2 years. The trial will involve 12 ALS patients who will receive stem cell injections in the lumbar area of the spinal cord. An information site for the disabled community adds hopefully: "If it makes it through all stages of testing, we will see if doctors are willing to [use] it on subjects that have injuries coming from physical injuries like diving accidents."
This discussion has been archived. No new comments can be posted.

FDA OKs First Human Trial of Neural Stem Cell Therapy

Comments Filter:

He has not acquired a fortune; the fortune has acquired him. -- Bion

Working...